These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1838257)

  • 41. Chronic myelocytic leukemia--Part I: History, clinical presentation, and molecular biology.
    Randolph TR
    Clin Lab Sci; 2005; 18(1):38-48. PubMed ID: 15747785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. KBM-7, a human myeloid leukemia cell line with double Philadelphia chromosomes lacking normal c-ABL and BCR transcripts.
    Andersson BS; Collins VP; Kurzrock R; Larkin DW; Childs C; Ost A; Cork A; Trujillo JM; Freireich EJ; Siciliano MJ
    Leukemia; 1995 Dec; 9(12):2100-8. PubMed ID: 8609723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The molecular biology diagnosis of neoplastic blood diseases].
    Teleheiev HD; Dybkov MV; Bozhko MV; Tretiak NM; Maliuta SS
    Tsitol Genet; 1998; 32(1):71-8. PubMed ID: 9695255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ABL and BCR genes are not imprinted in androgenetic and gynogenetic human tissues.
    Lorberboum-Galski H; Yarkoni S; Nechushtan A; Rachmilewitz J; deGroot N; Hochberg A
    Biochem Biophys Res Commun; 1994 Oct; 204(2):621-7. PubMed ID: 7980523
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
    Van Etten RA; Debnath J; Zhou H; Casasnovas JM
    Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic myeloid leukemia from basics to bedside.
    Thijsen S; Schuurhuis G; van Oostveen J; Ossenkoppele G
    Leukemia; 1999 Nov; 13(11):1646-74. PubMed ID: 10557038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Philadelphia chromosome-positive chronic myelogenous leukemia with deleted fusion of BCR and ABL genes.
    Ohyashiki K; Ohyashiki JH; Iwabuchi H; Tauchi T; Iwabuchi A; Toyama K
    Jpn J Cancer Res; 1990 Jan; 81(1):35-42. PubMed ID: 2157692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three-dimensional spectral precision distance microscopy of chromatin nanostructures after triple-colour DNA labelling: a study of the BCR region on chromosome 22 and the Philadelphia chromosome.
    Esa A; Edelmann P; Kreth G; Trakhtenbrot L; Amariglio N; Rechavi G; Hausmann M; Cremer C
    J Microsc; 2000 Aug; 199(Pt 2):96-105. PubMed ID: 10947902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignant transformation by abl and BCR/ABL.
    Van Etten RA
    Cancer Treat Res; 1992; 63():167-92. PubMed ID: 1363357
    [No Abstract]   [Full Text] [Related]  

  • 50. Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome.
    Kolomietz E; Marrano P; Yee K; Thai B; Braude I; Kolomietz A; Chun K; Minkin S; Kamel-Reid S; Minden M; Squire JA
    Leukemia; 2003 Jul; 17(7):1313-23. PubMed ID: 12835719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
    Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
    Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
    Ren SY; Xue F; Feng J; Skorski T
    Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells.
    Sattler M; Pride YB; Quinnan LR; Verma S; Malouf NA; Husson H; Salgia R; Lipkowitz S; Griffin JD
    Oncogene; 2002 Feb; 21(9):1423-33. PubMed ID: 11857085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel acute lymphoid leukaemia type BCR/ABL transcript in chronic myelogenous leukaemia.
    Okamoto K; Karasawa M; Sakai H; Ogura H; Morita K; Naruse T
    Br J Haematol; 1997 Mar; 96(3):611-3. PubMed ID: 9054670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversed BCR/ABL rearrangement detected by FISH in Philadelphia negative chronic myelocytic leukemia.
    Abeliovich D; Yehuda O; Krichevsky S; Nagler A; Ben-Neriah S; Werner M; Ludkovsky O; Ben-Yehuda D
    Cancer Genet Cytogenet; 1995 Jun; 81(2):115-7. PubMed ID: 7621406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Role of the three-dimensional distribution of abl and bcr genes in the formation of bcr/abl fusion gene in interphase neucleus].
    Zhang Q; Zhou SY; Liu XL; Niu C; Xu L; Chen SJ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):197-9. PubMed ID: 12390759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural organization of BCR-ABL gene in chronic phase and blast transformation in chronic myeloid leukemia patients.
    Martinelli G; Zaccaria A; Farabegoli P; Buzzi M; Testoni N; Bragliani M; Panzica G; Tura S
    Leuk Lymphoma; 1993; 11 Suppl 1():51-6. PubMed ID: 8251917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Leucemogenesis of chronic myelogenous leukemia].
    Mahon FX
    Rev Prat; 2005 Oct; 55(15):1642-6. PubMed ID: 16334200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoantibodies to Abl and Bcr proteins.
    Talpaz M; Qiu X; Cheng K; Cortes JE; Kantarjian H; Kurzrock R
    Leukemia; 2000 Sep; 14(9):1661-6. PubMed ID: 10995014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The molecular biology of chronic myeloid leukaemia.
    Melo JV
    Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.